Holen Sie sich die Stockscreener-App
83.90
0.70%
-0.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$84.49
Offen:
$84.3
24-Stunden-Volumen:
5.27M
Relative Volume:
1.19
Marktkapitalisierung:
$55.98B
Einnahmen:
$17.89B
Nettoeinkommen (Verlust:
$1.26B
KGV:
49.27
EPS:
1.7029
Netto-Cashflow:
$2.05B
1W Leistung:
-4.51%
1M Leistung:
+10.08%
6M Leistung:
+6.70%
1J Leistung:
+14.95%
1-Tages-Spanne:
$82.48
$84.49
1-Wochen-Bereich:
$82.48
$89.13
52-Wochen-Spanne:
$60.53
$90.97
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
83.90 | 55.98B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
78.45 | 37.44B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
133.07 | 20.14B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
25.19 | 8.01B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.66 | 7.31B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Herabstufung | UBS | Buy → Neutral |
| 2026-02-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
KeyBanc initiates Corteva stock at Sector Weight on spin-off concerns - Investing.com Australia
Chemours, DuPont, Corteva settle North Carolina PFAS claims for $455M - qz.com
Chemours, DuPont, Corteva reach $455 PFAS settlement with North Carolina - Manufacturing Dive
DuPont, Chemours, Corteva to pay $445M to settle ‘forever chemical’ suits - Delaware Business Now
CTVA Initiates Coverage On by Keybanc -- Rating Set to Sector We - GuruFocus
KeyCorp Upgrades Corteva (NYSE:CTVA) to Hold - MarketBeat
KeyCorp Predicts Corteva's Q3 Earnings (NYSE:CTVA) - MarketBeat
Corteva, Inc. $CTVA Shares Sold by Tidal Investments LLC - MarketBeat
Corteva, Inc. $CTVA Shares Sold by National Pension Service - MarketBeat
Corteva Inc (MIL:1CTVA) Stock Price, Trades & News - GuruFocus
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics - news.financial
Corteva (CTVA) Reaches $455 Million North Carolina PFAS Settleme - GuruFocus
Form 8K Corteva Inc For: 10 September By Investing.com - Investing.com Nigeria
Why Is Chemours Stock Trading Higher Today? - Benzinga
Chemours, DuPont, Corteva settle multi-million PFAS lawsuit with NC localities - Port City Daily
DuPont (DD) Reaches $455 Million PFAS Settlement With North Caro - GuruFocus
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million - Reuters
Corteva to Pay $66 Million in North Carolina PFAS Settlement - Minichart
Corteva to Pay About $66 Million in $455 Million North Carolina PFAS Settlement - minichart.com.sg
Corteva and partners agree to $455 million PFAS settlement with North Carolina - Investing.com Nigeria
Corteva Stock: Is CTVA Outperforming the Basic Material Sector? - inkl
Corteva, Chemours, and DuPont reach $455 million PFAS settlement with North Carolina By Investing.com - Investing.com South Africa
Chemours, DuPont and Corteva to Pay $455 Million in North Carolina PFAS Settlement - WSJ
Corteva, Chemours, and DuPont reach $455 million PFAS settlement with North Carolina - Investing.com
North Carolina reaches $455 million PFAS settlement with Chemours, DuPont and Corteva - WRAL
DuPont, Chemours, and Corteva settle North Carolina PFAS claims - StreetInsider
DuPont, Chemours, Corteva reach $455M North Carolina 'forever chemicals' settlement (DD:NYSE) - Seeking Alpha
A $455 million settlement covers North Carolina contamination claims - Stock Titan
Chemours, DuPont and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina - PR Newswire
Trading Systems Reacting to (CTVA) Volatility - Stock Traders Daily
Corteva Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corteva Can Seek Foreign-Linked Damages at Inari Seed-Tech Trial - Bloomberg Law News
Corteva and Globachem form 50/50 crop protection JV - grafa.com
Corteva, Inc. and Globachem N.V. Enter into Definitive Agreement to Form Joint Venture to Advance Development and Commercialization of New Formulated Crop Protection Solutions - marketscreener.com
CTVA Looks 28.3% Overvalued on GF Value™ - GuruFocus
Corteva, Globachem form crop protection joint venture By Investing.com - Investing.com Canada
Corteva, Globachem to Launch Joint Venture Focused on New Crop Protection Solutions - marketscreener.com
Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions - PR Newswire
California State Teachers Retirement System Grows Holdings in Corteva, Inc. $CTVA - MarketBeat
Amundi Has $183.06 Million Stock Holdings in Corteva, Inc. $CTVA - MarketBeat
Corteva Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Vylor launches a new era in corn - Ethanol Producer Magazine
Is Corteva (NYSE:CTVA) Priced for A Bigger Vylor Win? - Kalkine Media
Will Higher Peru Output Strengthen Mission Produce's Outlook? - TradingView
Vylor Edge Launch: Investment Platform for Emerging Ag Technologies | VylorNews and Statistics - IndexBox
Weekly Recap: Vylor spin-off and Corteva Inc shares drop 6% - TradingView
Saudi Central Bank Acquires 22,052 Shares of Corteva, Inc. $CTVA - MarketBeat
NEOS Investment Management LLC Purchases 12,819 Shares of Corteva, Inc. $CTVA - MarketBeat
Nykredit A S Takes $15.51 Million Position in Corteva, Inc. $CTVA - MarketBeat
Corteva’s Patent Infringement Theories Survive for Jury Trial - Bloomberg Law News
Vylor Launches Vylor Edge Investment Platform for Ag Innovation - iGrow News
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):